Recent Transactions

Co-Promotion Partnership for the US
​

$35,000,000
​Strategic Advisor

Out-license to SeaGen

​

$700,000,000
​Strategic Consultant

Capital Raise

​

$35,000,000
​Financial Advisor

Acquisition by West-Atlantic Partners

Not Disclosed
​Strategic Advisor

Out-license of regional rights for Apealea to Inceptua Group

Not Disclosed
Strategic Advisor

Investment by
BDI Col Ltd.​
​

$12,000,000
​Placement Agent

Acquisition by BioNano Genomics​

$10,740,000
​Strategic Advisor

Out-license of Apealea to ​Elevar Therapeutics

$698,000,000
​Strategic Advisor

Series E Convertible Bridge Note

Not Disclosed
Strategic Advisor

​Merger with HLB
​
​

$212,000,000
​Strategic Advisor

​Series D Convertible Bridge Note

Not Disclosed
Strategic Advisor

Strategic consulting assignment​

N/A
​Strategic Advisor

Out-license of Intrarosa to AMAG Pharmaceuticals​

$234,310,000
​Strategic Advisor

​Out-license of platform technology
​

Not Disclosed
Strategic Advisor

Term Loan Credit Facility with CRG​
​
​

$85,000,000
Strategic Advisor

Acquisition of minority stake
​by West Pharmaceuticals

Not Disclosed
Strategic Advisor

Out-license of Phase II drug

​

Not Disclosed
Strategic Advisor

Sale of Company
​
​

$90,000,000
​Sell-side Advisor

Sale of Company
​
​

$159,400,000
​Sell-side Advisor

Merger of two vaccine companies

Not Disclosed
Strategic Advisor

Out-license to Large Pharma
​

Not Disclosed
Strategic Advisor

Sale of Company to Celsion Inc​.
​

$44,400,000
​Strategic Advisor

Out-license of RSV asset to Merck

Not Disclosed
Strategic Advisor

Acquisition of royalties from DepoMed​

$240,500,000
​Buy-side Advisor

JV with ISU
​Abxis Co. to
develop F-IX​

Not Disclosed
Strategic Advisor

Registered Direct Offering
​

$100,000,000​Manager

Out-license of China rights to IMP321

Not Disclosed
​​Strategic Advisor

Registered Direct Offering

$7,800,000
Exclusive Placement Agent

Out-license
​to R-Pharm
​

Not Disclosed
​​Strategic Advisor

Follow-on Offering​

$10,790,000​​Exclusive Placement Agent

Sub-license of rotavirus vaccine


​Not Disclosed
​​Strategic Advisor

Registered Direct Offering​


​$5,000,000
​Placement Agent

Follow-on Offering

$6,300,000
Co-lead Underwriter

Valuation for loan against royalty stream
​

$50,000,000
Strategic Advisor

Merger with Cytomedix

​

$40,000,000
Strategic Advisor

Acquisition of
ex-U.S. rights to ZEBALIN
​from Bayer

$25,000,000
Buy-side Advisor

​JV with Biogen IDEC to develop biosimilars
​

$300,000,000
Strategic Advisor

Divestiture of 3 programs
​

Not Disclosed
​Sell-side Advisor

Divestiture of business unit to Evotec

$18,000,000
Sell-side Advisor

Out-license of Asian rights to lead compound

$84,000,000
Strategic Advisor

License of
pre-clinical
​asset to GSK

$100,000,000
Strategic Advisor